ATE319819T1 - Humane hirn-spezifische carboxypeptidase b - Google Patents
Humane hirn-spezifische carboxypeptidase bInfo
- Publication number
- ATE319819T1 ATE319819T1 AT00922936T AT00922936T ATE319819T1 AT E319819 T1 ATE319819 T1 AT E319819T1 AT 00922936 T AT00922936 T AT 00922936T AT 00922936 T AT00922936 T AT 00922936T AT E319819 T1 ATE319819 T1 AT E319819T1
- Authority
- AT
- Austria
- Prior art keywords
- human brain
- specific carboxypeptidase
- carboxypeptidase
- specific
- gene
- Prior art date
Links
- 102000003670 Carboxypeptidase B Human genes 0.000 title 1
- 108090000087 Carboxypeptidase B Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000005367 Carboxypeptidases Human genes 0.000 abstract 1
- 108010006303 Carboxypeptidases Proteins 0.000 abstract 1
- 210000001320 hippocampus Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Hydrogenated Pyridines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12516999 | 1999-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319819T1 true ATE319819T1 (de) | 2006-03-15 |
Family
ID=14903603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00922936T ATE319819T1 (de) | 1999-04-30 | 2000-05-01 | Humane hirn-spezifische carboxypeptidase b |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7060266B1 (de) |
| EP (1) | EP1179588B9 (de) |
| JP (1) | JP4579422B2 (de) |
| AT (1) | ATE319819T1 (de) |
| AU (1) | AU4316600A (de) |
| DE (1) | DE60026501T2 (de) |
| ES (1) | ES2260011T3 (de) |
| WO (1) | WO2000066717A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060266B1 (en) | 1999-04-30 | 2006-06-13 | Akira Matsumoto | Human brain carboxypeptidase B |
| US6455294B1 (en) * | 2001-03-21 | 2002-09-24 | Applera Corporation | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| US7291587B2 (en) | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
| WO2003076572A2 (en) | 2002-03-04 | 2003-09-18 | Bristol-Myers Squibb Company | Novel nucleic acid molecules and polypeptides encoding baboon tafi |
| EP1380290A1 (de) * | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-Beta-Strukturweg und seine therapeutische Relevanz |
| EP1794294B1 (de) * | 2004-09-27 | 2011-07-20 | Sanofi-Aventis Deutschland GmbH | Rekombinante carboxypeptidase b |
| US7807789B2 (en) * | 2004-12-21 | 2010-10-05 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in EGFR-signaling pathways |
| US8114832B2 (en) | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
| AU2006267176A1 (en) | 2005-07-13 | 2007-01-18 | Crossbeta Biosciences B.V. | Cross-beta structure binding compounds |
| KR100851035B1 (ko) * | 2005-08-23 | 2008-08-11 | 대한민국 | GCP-Ⅱ를 유효성분으로 함유하는 β-아밀로이드의 뇌내축적 예방 및 치료용 약학적 조성물과 치료제 스크리닝용조성물 및 이를 이용한 스크리닝 방법 |
| JP5775356B2 (ja) * | 2011-05-09 | 2015-09-09 | 松本 明 | 神経保護作用を有するペプチド及びこれを含む薬剤 |
| US8877446B2 (en) * | 2011-08-26 | 2014-11-04 | Korea Research Institute Of Bioscience And Biotechnology | Method for detecting protein-protein interactions in cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206161A (en) * | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| US5985562A (en) | 1997-06-03 | 1999-11-16 | Schering Aktiengesellschaft | Method of detecting thrombotic disease risk associated with plasma carboxypeptidase B polymorphisms |
| US7060266B1 (en) | 1999-04-30 | 2006-06-13 | Akira Matsumoto | Human brain carboxypeptidase B |
-
2000
- 2000-05-01 US US09/980,881 patent/US7060266B1/en not_active Expired - Lifetime
- 2000-05-01 EP EP00922936A patent/EP1179588B9/de not_active Expired - Lifetime
- 2000-05-01 DE DE60026501T patent/DE60026501T2/de not_active Expired - Lifetime
- 2000-05-01 AT AT00922936T patent/ATE319819T1/de not_active IP Right Cessation
- 2000-05-01 AU AU43166/00A patent/AU4316600A/en not_active Abandoned
- 2000-05-01 ES ES00922936T patent/ES2260011T3/es not_active Expired - Lifetime
- 2000-05-01 WO PCT/JP2000/002878 patent/WO2000066717A1/ja not_active Ceased
- 2000-05-01 JP JP2000615742A patent/JP4579422B2/ja not_active Expired - Lifetime
-
2005
- 2005-09-22 US US11/233,958 patent/US7524934B2/en not_active Expired - Fee Related
-
2009
- 2009-03-18 US US12/406,925 patent/US7972771B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60026501T2 (de) | 2006-08-10 |
| AU4316600A (en) | 2000-11-17 |
| DE60026501D1 (en) | 2006-05-04 |
| ES2260011T3 (es) | 2006-11-01 |
| EP1179588A1 (de) | 2002-02-13 |
| US20100021951A1 (en) | 2010-01-28 |
| US7524934B2 (en) | 2009-04-28 |
| US20060024760A1 (en) | 2006-02-02 |
| JP4579422B2 (ja) | 2010-11-10 |
| WO2000066717A1 (fr) | 2000-11-09 |
| EP1179588B1 (de) | 2006-03-08 |
| EP1179588A4 (de) | 2004-04-07 |
| US7060266B1 (en) | 2006-06-13 |
| EP1179588B9 (de) | 2006-07-19 |
| US7972771B2 (en) | 2011-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60142614D1 (de) | Inität | |
| ITTO950367A0 (it) | Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti. | |
| ATE180261T1 (de) | Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen | |
| FI963101A7 (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoo n, joissa seerumin interleukiini-6-taso on kohonnut | |
| DE68911120D1 (de) | Knochenraspel. | |
| EE05492B1 (et) | Farmatseutilised kompositsioonid, nendega seotud meetodid ja nende kasutamine amloidogeensete haiguste korral | |
| ATE346303T1 (de) | Mit alzheimer krankheit verknüpften verfahren zur diagnose, zur herstellung von medikamenten und zum screenen von substanzen sowie aus beta- amyloid abgeleiteten peptiden | |
| NO995458L (no) | Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder | |
| ATE391781T1 (de) | Transgenes tier welches das trunkierte alzheimer tau protein exprimiert | |
| ES2153671T3 (es) | Peptidos neuroactivos. | |
| ATE319819T1 (de) | Humane hirn-spezifische carboxypeptidase b | |
| DK1887014T3 (da) | Humane Toll-homologer | |
| ATE295423T1 (de) | Phosphodiesterase 8 | |
| DE69943022D1 (de) | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor | |
| ATE254476T1 (de) | 88kda tumorgener wachstumsfaktor und antagonisten | |
| DE69634918D1 (de) | Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie | |
| EP1023906A4 (de) | Verstärker für antikörper gegen lymphoiden tumor | |
| TR200000416T2 (tr) | Neisseria loctoferrin bağlayıcı protein. | |
| DE60113968D1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| DE69734890D1 (de) | Rdgb-proteine | |
| WO1998020124A3 (en) | Diabetes-mediating proteins and therapeutic uses thereof | |
| ATE407944T1 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
| EP1191096A4 (de) | Neues protein und dessen dns | |
| WO2000042165A3 (en) | Bone marrow-specific protein | |
| ATE336503T1 (de) | Cyclophilin als allergen identifiziert |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |